Dermovate 0.05 % w/w Ointment Ireland - English - HPRA (Health Products Regulatory Authority)

dermovate 0.05 % w/w ointment

lexon (uk) ltd - clobetasol propionate - ointment - 0.05 percent weight/weight - corticosteroids, very potent (group iv); clobetasol

Dermovate 0.05 % w/w Ointment Ireland - English - HPRA (Health Products Regulatory Authority)

dermovate 0.05 % w/w ointment

lexon pharmaceuticals (ireland) limited - clobetasol propionate - ointment - 0.05 percent weight/weight - corticosteroids, very potent (group iv); clobetasol

DERMOVATE OINTMENT Israel - English - Ministry of Health

dermovate ointment

glaxo smith kline (israel) ltd - clobetasol 17- propionate - ointment - clobetasol 17- propionate 0.05 %w/w - clobetasol - clobetasol - clobetasol is a very potent topical corticosteroid indicated for adults, elderly and children over 1 year for the short term treatment only of more resistant inflammatory and pruritic manifestations of steroid responsive dermatoses unresponsive to less potent corticosteroids. these include the following:• psoriasis (excluding widespread plaque psoriasis)• recalcitrant dermatoses •lichen planus• discoid lupus erythematosus • other skin conditions which do not respond satisfactorily to less potent steroids.

DERMOVATE SCALP APPLICATION Israel - English - Ministry of Health

dermovate scalp application

glaxo smith kline (israel) ltd - clobetasol propionate - solution - external - clobetasol propionate 0.05 %w/w - clobetasol - clobetasol - for the topical treatment of inflammatory conditions of the scalp responsive only to corticosteroids.

DERMOVATE CREAM Israel - English - Ministry of Health

dermovate cream

glaxo smith kline (israel) ltd - clobetasol 17- propionate - cream - clobetasol 17- propionate 0.05 %w/w - clobetasol - clobetasol - clobetasol is a very potent topical corticosteroid indicated for adults, elderly and children over 1 year for the short term treatment only of more resistant inflammatory and pruritic manifestations of steroid responsive dermatoses unresponsive to less potent corticosteroids. these include the following:• psoriasis (excluding widespread plaque psoriasis)• recalcitrant dermatoses • lichen planus• discoid lupus erythematosus • other skin conditions which do not respond satisfactorily to less potent steroids.

Dermovate 0.05% w/w Cream Ireland - English - HPRA (Health Products Regulatory Authority)

dermovate 0.05% w/w cream

glaxosmithkline (ireland) limited - clobetasol propionate - cream - 0.05 percent weight/weight - corticosteroids, very potent (group iv); clobetasol

Dermovate 0.05% w/w Ointment Ireland - English - HPRA (Health Products Regulatory Authority)

dermovate 0.05% w/w ointment

glaxosmithkline (ireland) limited - clobetasol propionate - ointment - 0.05 percent weight/weight - corticosteroids, very potent (group iv); clobetasol

Dermovate 0.05% w/w Cream Malta - English - Medicines Authority

dermovate 0.05% w/w cream

glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - clobetasol propionate - cream - clobetasol propionate 0.525 % (w/w) - corticosteroids, dermatological preparations

Dermovate 0.05% w/w Ointment Malta - English - Medicines Authority

dermovate 0.05% w/w ointment

glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - clobetasol propionate - ointment - clobetasol propionate 0.05375 % (w/w) - corticosteroids, dermatological preparations

Dermovate 0.5 mg/g Cream Malta - English - Medicines Authority

dermovate 0.5 mg/g cream

neofarma pharmaceuticals limited 42-46, mill street, qormi, qrm 3105, malta - cream - clobetasol propionate 0.5 mg/g - corticosteroids, dermatological preparations